Sign in
4

Changes in Ownership

XBiotech Inc. Filed Acc 0000950170-24-002316

Options or other derivatives

  • Chief Executive Officer bought 2,470,355 shares at $10,000,000.00 ($24,703,550,000,000)

From the SEC's structured data for this filing

Trades in this filing

SIMARD JOHN · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-03 Purchase : show line 1 in the form Convertible Loan Agreement +2,470,355 $10,000,000.00 $24,703,550,000,000 3,840,736 D
Loading xslF345X05/ownership.xml…